共 187 条
[1]
Backstrom M(2007)Adverse drug reaction reporting by nurses in Sweden Eur J Clin Pharmacol 63 613-618
[2]
Ekman E(2013)Gathering and exploring scientific knowledge in pharmacovigilance PLoS One 8 e83016-92
[3]
Mjorndal T(2004)Differences between clinical trials and postmarketing use Br J Clin Pharmacol 57 86-437
[4]
Lopes P(1999)Reporting of adverse effects in clinical trials should be improved: lessons from acute postoperative pain J Pain Symptom Manag 18 427-443
[5]
Nunes T(2001)Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas JAMA 285 437-123
[6]
Campos D(2007)What have we learnt from Vioxx? Bmj 334 120-570
[7]
Furlong LI(2010)Rosiglitazone: what went wrong? Bmj 341 c4848-280
[8]
Bauer-Mehren A(2011)Secondary use of randomized controlled trials to evaluate drug safety: a review of methodological considerations Clin Trials 8 559-101
[9]
Sanz F(2016)Best practice for analysis of shared clinical trial data BMC Med Res Methodol 16 76-64
[10]
Carrascosa MC(2001)Reporting of adverse drug reactions in randomised controlled trials-a systematic survey BMC Clin Pharmacol 1 3-1110